(Q35009755)

5 August 2017

1 reference

title

Mood stabilizers in Alzheimer's disease: symptomatic and neuroprotective rationales (English)

1 reference

5 August 2017

0 references

Pierre N Tariot

1

1 reference

5 August 2017

Rebekah Loy

2

1 reference

5 August 2017

J Michael Ryan

3

1 reference

5 August 2017

Anton Porsteinsson

4

1 reference

5 August 2017

Saleem Ismail

5

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

Advanced Drug Delivery Reviews

5 August 2017

1 reference

5 August 2017

54

1 reference

5 August 2017

1567-1577

1 reference

5 August 2017

12

1 reference

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Incidence of and risk factors for hallucinations and delusions in patients with probable AD.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Longitudinal changes in behavioral problems in old age: a study in an adult day care population

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Behavior Rating Scale for Dementia: development of test scales and presentation of data for 555 individuals with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Natural history of behavioural changes and psychiatric symptoms in Alzheimer's disease. A longitudinal study.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Agitated behaviors in the elderly. I. A conceptual review

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Psychiatric symptoms in patients with dementia predict the later development of behavioural abnormalities.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Carbamazepine treatment of agitation associated with dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Carbamazepine treatment of agitation in nursing home patients with dementia: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Anticonvulsant and other non-neuroleptic treatment of agitation in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Efficacy and tolerability of carbamazepine for agitation and aggression in dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Up-regulation of sodium channel subunit mRNAs and their cell surface expression by antiepileptic valproic acid: activation of calcium channel and catecholamine secretion in adrenal chromaffin cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Anticonvulsants attenuate amyloid beta-peptide neurotoxicity, Ca2+ deregulation, and cytoskeletal pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Valproic acid suppresses the synaptic response mediated by the NMDA receptors in rat amygdalar slices.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Valproate suppresses N-methyl-D-aspartate-evoked, transient depolarizations in the rat neocortex in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Mood stabilizers: shared mechanisms of action at postsynaptic signal-transduction and kindling processes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Evidence that NMDA-dependent limbic neural plasticity in the right hemisphere mediates pharmacological stressor (FG-7142)-induced lasting increases in anxiety-like behavior. Study 1--Role of NMDA receptors in efferent transmission from the cat amygd

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Role of N-methyl-D-aspartic acid and cholecystokinin receptors in apomorphine-induced aggressive behaviour in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Ethological analysis of the effects of MK-801 upon aggressive male mice: similarity to chlordiazepoxide

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Decreased expression of N-methyl-D-aspartate receptor 1 messenger RNA in select regions of Alzheimer brain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Carbamazepine inhibits NMDA-induced depolarizations in cortical wedges prepared from DBA/2 mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

A novel action of lithium: stimulation of glutamate release and inositol 1,4,5 trisphosphate accumulation via activation of the N-methyl D-aspartate receptor in monkey and mouse cerebral cortex slices

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

NMDA receptor type 2D gene as target for estrogen receptor in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Anticonvulsant activity of melatonin against seizures induced by quinolinate, kainate, glutamate, NMDA, and pentylenetetrazole in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Effect of the NMDA-antagonist, MK 801, on benzodiazepine-opioid interactions at the spinal and supraspinal level in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Repeated administrations of (-)-deprenyl increase [3H]MK801 binding in rat brain and antagonize the impairment of passive avoidance conditioning induced by N-methyl-D-aspartate receptor antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

A glutamatergic model of ECT-induced memory dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Beta-adrenergic regulation of synaptic NMDA receptors by cAMP-dependent protein kinase.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Acetylcholine enhances NMDA-evoked calcium rise in hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Regional effects of sodium valproate on extracellular concentrations of 5-hydroxytryptamine, dopamine, and their metabolites in the rat brain: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Effects of valproic acid on beta-adrenergic receptors, G-proteins, and adenylyl cyclase in rat C6 glioma cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Modulation of protein kinase C isozymes and substrates by lithium: the role of myo-inositol

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Anti-bipolar therapy: mechanism of action of lithium

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Neuronal apoptosis induced by beta-amyloid is mediated by caspase-8.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

The renaissance of GSK3

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Possible role of tau protein kinases in pathogenesis of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3beta in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Valproate robustly enhances AP-1 mediated gene expression.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

Neuroplasticity and cellular resilience in mood disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2802%2900153-9

7 January 2021

10.1016/S0169-409X(02)00153-9

Identifiers

DOI

1 reference

5 August 2017

1 reference